Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Francisco Almazán"'
Autor:
Dinakantha S. Kumararatne, Xavier Bossuyt, Toshiro Hara, Cyrille Hoarau, László Maródi, Nicolas Sirvent, Claudia Fortuny, Capucine Picard, Joseph B. Domachowske, Horst von Bernuth, Maria Méndez, John I. Gallin, Jean-Laurent Casanova, Laia Alsina, Simona Eva Zitnik, Abdulaziz Al-Ghonaium, David P. Speert, Anne Puel, Artur Bonito Vitor, Carlos Rodrigo, Noorbibi K. Day-Good, Juan I. Aróstegui, Chaim M. Roifman, E. Graham Davies, Júlia Vasconcelos, Hidetoshi Takada, Raif S. Geha, Sami Al-Hajjar, C. Buddy Creech, Carlos Rodríguez-Gallego, Mimi L.K. Tang, Douglas R. McDonald, Yildiz Camcioglu, Joanne Smart, Rainer Döffinger, Jens C. Krause, James W. Verbsky, Ofer Levy, Adrian J. Thrasher, Margarida Guedes, Dominique De Ricaud, Helen Chapel, Elena Colino, Andrew C. Issekutz, Steven M. Holland, Claire Bethune, Hideto Yoshikawa, Stephan Ehl, Saleh Al-Muhsen, Ben Zion Garty, Maya Chrabieh, Cheng-Lung Ku, Shigeaki Nonoyama, Janine Reichenbach, Pegah Ghandil, Francisco Almazán, Laurent Abel, Peter D. Arkwright
Publikováno v:
Medicine. 89:403-425
Autosomal recessive interleukin-1 receptor-associated kinase (IRAK)-4 and myeloid differentiation factor (MyD)88 deficiencies impair Toll-like receptor (TLR)- and interleukin-1 receptor-mediated immunity. We documented the clinical features and outco
Autor:
Javier Francisco, Almazán Romero, Alvarez Vega, Penélope Guadalupe, Monroy Meléndez, Dinora, Gamboa Yuriar, Magaly Lizeth
Publikováno v:
Congreso Internacional de Investigacion Academia Journals; 2018, Vol. 10 Issue 5, p24-27, 4p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Josep-Maria Ribera, Francisco Almazán, Susana Vives, Joan-Ramon Grifols, Juan-Manuel Sancho, Jordi Juncà
Publikováno v:
Journal of Clinical Apheresis. 27:260-262
Some malignant tumors in childhood require high-dose chemotherapy with stem cell support to achieve a cure. In patients heavily pretreated with myelosuppressive chemotherapy or irradiation, granulocyte colony-stimulating factor (G-CSF) may fail to mo